The Taiwan Monthly
Home
Previous Issues
Sep. 2026
Aug. 2026
Jul. 2026
Jun. 2026
May. 2026
Apr. 2026
Mar. 2026
Feb. 2026
Jan. 2026
Dec. 2025
Nov. 2025
Oct. 2025
Sep. 2025
Aug. 2025
Jul. 2025
Jun. 2025
May. 2025
Apr. 2025
Mar. 2025
Feb. 2025
Jan. 2025
Dec. 2024
Nov. 2024
Oct. 2024
Sep. 2024
Aug. 2024
Jul. 2024
Jun. 2024
May. 2024
11 Apr. 2024
Apr. 2024
Mar. 2024
Feb. 2024
Jan. 2024
Dec. 2023
Nov. 2023
Oct. 2023
Sep. 2023
17 Aug. 2023
Aug. 2023
20 Jul. 2023
Jul. 2023
Jun. 2023
May. 2023
Apr. 2023
Mar. 2023
Feb. 2023
Jan. 2023
Dec. 2022
Nov. 2022
Oct. 2022
Sep. 2022
Aug. 2022
Jul. 2022
Jun. 2022
May. 2022
Apr. 2022
Mar. 2022
Feb. 2022
Jan. 2022
Dec. 2021
Nov. 2021
Oct. 2021
Sep. 2021
Aug. 2021
Jul. 2021
Jun. 2021
May. 2021
Apr. 2021
Mar. 2021
Feb. 2021
Jan. 2021
Dec. 2020
Nov. 2020
Oct. 2020
Sep. 2020
Aug. 2020
Jul. 2020
Jun. 2020
May. 2020
Apr. 2020
Mar. 2020
Feb. 2020
Jan. 2020
Dec. 2019
Nov. 2019
Oct. 2019
Sep. 2019
Aug. 2019
Jul. 2019
Jun. 2019
May. 2019
Apr. 2019
Mar. 2019
Feb. 2019
Jan. 2019
Dec. 2018
Nov. 2018
Oct. 2018
Sep. 2018
Aug. 2018
Jul. 2018
Jun. 2018
May. 2018
Apr. 2018
Mar. 2018
Feb. 2018
Jan. 2018
Dec. 2017
Nov. 2017
TWSE Website
Subscribe
The Taiwan Monthly
May 2026
LinkedIn
Twitter
Facebook
Email
print
download
Back
Listed Companies and Initial Public Offerings
TAHO Pharmaceuticals Ltd. has submitted its application for listing on the TWSE on March 27, 2026
Back